AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy.
Kagiava A, Karaiskos C, Richter J, Tryfonos C, Jennings MJ, Heslegrave AJ, Sargiannidou I, Stavrou M, Zetterberg H, Reilly MM, Christodoulou C, Horvath R, Kleopa KA.
Kagiava A, et al. Among authors: tryfonos c.
Gene Ther. 2021 Nov;28(10-11):659-675. doi: 10.1038/s41434-021-00250-0. Epub 2021 Mar 10.
Gene Ther. 2021.
PMID: 33692503
Free PMC article.